Skip to content
Search

Latest Stories

Scottish government launches campaign to raise awareness about drug overdose

The Scottish Government and Scottish Drugs Forum (SDF) have launched a campaign to raise public awareness about drug overdose and the life-saving medication naloxone.

Naloxone is a medication used to reverse the effects of opioids-related overdose.


The launch of the national campaign marks the International Overdose Awareness Day (August 31).

It will use TV, radio adverts and billboards at transport hubs and shopping centres to persuade people to visit the StopTheDeaths website and learn about signs of an overdose.

The website will also give information about how to get a naloxone kit and provide training to use it.

Scottish Drugs policy minister Angela Constance said: “As I have said before, the number of deaths in Scotland is heart-breaking and I am determined that every penny of the £250 million we will spend on the crisis over the next five years will make a difference.

According to government data, in 2020, 1,339 people died because of drug overdose in Scotland, marking the seventh consecutive year of a record number of drug-related deaths.

She said: “It will help inform a wider audience of what naloxone is, how it works and how they can use it in an emergency.

“Naloxone is one of a wide range of measures being used to address the public health emergency of drugs deaths, but it plays an important role”.

Kirsten Horsburgh, Strategy Coordinator for Drug Death Prevention at Scottish Drugs Forum, said: “In the time people wait for an ambulance the first steps can be made that can save that person’s life.  Recognising that someone may be experiencing an overdose, dialling 999 and administering naloxone are all part of the response that gives that person the best chance of recovery.

“In Scotland there is widespread access to naloxone kits and training and it’s crucial that as many people as possible get involved.”

More For You

MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less
Pharmacies in Northern Ireland distribute free booklets to raise cancer awareness

Dr Anna Cullen, Public Health Registrar at the Public Health Agency and Clare Conroy, Community Pharmacist from Meigh Pharmacy in Co Down.

Photo credit: Community Pharmacy Northern Ireland

Pharmacies in Northern Ireland help raise cancer awareness

Community pharmacies across Northern Ireland are distributing a free information booklet to help raise public awareness of the signs and symptoms of cancer and promote early diagnosis.

The initiative is part of the ‘Be Cancer Aware’ campaign, which has been running in pharmacies since April and will continue through May as part of the Living Well service.

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less
Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less